Data / Form D filings / ImmPACT Bio USA Inc.
ImmPACT Bio USA Inc.: Form D filings
ImmPACT Bio USA Inc., a biotechnology company in West Hills, CA, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on April 2, 2024, reports $139.9 million sold of a $141.8 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8501 Fallbrook Avenue, Suite 200, West Hills, CA, 91304
- Phone
- (805) 437-9706
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1820064
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | Amendment | $141,755,472 | $139,855,923 | $1,899,549 | 15 | Jan 14, 2022 | sec.gov |
| Jan 20, 2022 | New notice | $110,855,843 | $110,855,843 | 13 | Jan 14, 2022 | sec.gov | |
| Aug 5, 2020 | New notice | $5,500,000 | $3,750,000 | $1,750,000 | 17 | Jul 16, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yvonne Yu-Hsuan Chen | Director | |
| Erez Chimovits | Director | |
| Han Yu-Hsuan Lee | Executive Officer | |
| Michal Silverberg | Director | |
| Xiangmin Yu-Hsuan Cui | Director | |
| Sheila Yu-Hsuan Guirathi | Director | |
| Sumant Ramachandra | Executive Officer, Director | |
| Yvonne Yamanaka | Director | |
| Cindy Xiong | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 1, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ImmPACT Bio USA Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.